Sarepta Therapeutics, Inc. (SRPT)


NasdaqGS - NasdaqGS Real Time Price. Currency in USD
59.10-0.56 (-0.94%)
At close: 4:00 PM EDT

59.55 0.45 (0.76%)
Pre-Market: 4:03 AM EDT

People also watch:
ACADCLVSCLDXPTCTICPT
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Open59.05
Prev Close59.66
Bid59.46 x 200
Ask59.74 x 100
Day's Range57.71 - 59.94
52wk Range8.00 - 61.60
1y Target EstN/A
Market Cap2.83B
P/E Ratio (ttm)-11.04
Beta1.71
Volume3,024,607
Avg Vol (3m)3,971,959
Dividend & YieldN/A (N/A)
Earnings DateN/A
Trade prices are not sourced from all markets
  • Investopedia14 hours ago

    Sarepta’s Manufacturing Challenge (SRPT)

    Amid doubts about scalability of manufacturing, Sarepta has laid out plans to serve the high unmet demand for the approved drug.

  • Investopedia2 days ago

    BioMarin Takes Aim at Rival Sarepta (BMRN, SRPT)

    Following its loss in a U.S. patent infringement ruling, BioMarin is taking further steps agains rival Sarepta

  • Why Wells Fargo, Sarepta, Delphi, UPS, and More Are Making Headlines
    Insider Monkey2 days ago

    Why Wells Fargo, Sarepta, Delphi, UPS, and More Are Making Headlines

    With the U.S. Presidential debate on September 26 expected to draw a massive audience, many traders are eagerly anticipating the latest polling numbers to see what economic direction the U.S. will inch towards. If Clinton wins, the U.S. will likely remain pro-free trade, while if Trump wins, America will put itself first. In this article, […]